Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 7/20 | 0.50 |
| ▸ | DAO | P14920 | 1/20 | 0.38 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.38 |
| ▸ | MAOA | P21397 | 3/20 | 0.38 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.38 |
| ▸ | KDM1A | O60341 | 1/20 | 0.37 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.37 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.37 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.37 |
| ▸ | PAOX | Q6QHF9 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5384592 | 1.00 | MAOB (0.50) | MAOBDAOHRH3MAOASLC2A1 | |
| SCHEMBL5381193 | 1.00 | MAOB (0.50) | MAOBDAOHRH3MAOASLC2A1 | |
| SCHEMBL5402489 | 1.00 | MAOB (0.50) | MAOBDAOHRH3MAOASLC2A1 | |
| SCHEMBL5392826 | 0.98 | MAOB (0.49) | MAOBDAOHRH3MAOASLC2A1 | |
| SCHEMBL5400666 | 0.92 | MAOB (0.46) | MAOBDAOHRH3MAOASLC2A1 | |
| SCHEMBL6663625 | 0.89 | MAOB (0.57) | MAOBDAOHRH3MAOASLC2A1 | |
| SCHEMBL6656793 | 0.87 | MAOB (0.56) | MAOBDAOHRH3MAOASLC2A1 | |
| SCHEMBL1787980 | 0.83 | DAO (0.42) | MAOBDAOHRH3MAOASLC2A1 | |
| SCHEMBL23349399 | 0.83 | MAOB (0.56) | MAOBDAOHRH3MAOASLC2A1 | |
| SCHEMBL6658550 | 0.83 | MAOB (0.56) | MAOBDAOHRH3MAOASLC2A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8461375-B2 | Method for the continuous production of alkyl(meth)acrylates with multiple catalyst recycling | EVONIK RÖHM GMBH (DE) | 2013-06-11 | — | — | US | disclosed |
| EP-1583733-B1 | IMPROVED METHOD FOR THE CONTINUOUS PRODUCTION OF ALKYL(METH)ACRYLATES WITH MULTIPLE CATALYST RECYCLING | EVONIK ROEHM GMBH (DE) | 2013-04-24 | — | — | EP | disclosed |
| EP-1399409-B1 | METHOD FOR PRODUCING (METH)ACRYLIC ACID ESTERS | BASF SE (DE) | 2012-10-31 | — | — | EP | disclosed |
| US-7268251-B2 | Method for producing (meth) acrylic acid esters | BASF AKTIENGESELLSCHAFT (DE) | 2007-09-11 | — | — | US | disclosed |
| US-20060211880-A1 | Method for the continuous production of alkyl(meth)acrylates with multiple catalyst recycling | ROEHM GMBH & CO. KG (DE) | 2006-09-21 | — | — | US | disclosed |
| US-7026503-B2 | Method for producing (meth)acrylic acid esters | BASF AKTIENGESELLSCHAFT (DE) | 2006-04-11 | — | — | US | disclosed |
| EP-1399408-B1 | METHOD FOR PRODUCING (METH)ACRYLIC ACID ESTERS | BASF AG (DE) | 2006-03-22 | — | — | EP | disclosed |
| EP-1583733-A1 | IMPROVED METHOD FOR THE CONTINUOUS PRODUCTION OF ALKYL(METH)ACRYLATES WITH MULTIPLE CATALYST RECYCLING | Röhm GmbH & Co. KG (DE) | 2005-10-12 | — | — | EP | disclosed |
| US-20040171868-A1 | Method for producing (meth) acrylic acid esters | BASF AKTIENGESELLSCHAFT (DE) | 2004-09-02 | — | — | US | disclosed |
| CN-1525953-A | Method for producing (meth) acrylic acid esters | �����ɷ� | 2004-09-01 | — | — | CN | disclosed |
| US-20040158096-A1 | Method for producing (meth)acrylic acid esters | BASF AKTIENGESELLSCHAFT (DE) | 2004-08-12 | — | — | US | disclosed |
| WO-2004063140-A1 | IMPROVED METHOD FOR THE CONTINUOUS PRODUCTION OF ALKYL(METH)ACRYLATES WITH MULTIPLE CATALYST RECYCLING | Röhm GmbH & Co. KG (DE) | 2004-07-29 | — | — | WO | disclosed |
| EP-1399408-A1 | METHOD FOR PRODUCING (METH)ACRYLIC ACID ESTERS | BASF AKTIENGESELLSCHAFT (DE) | 2004-03-24 | — | — | EP | disclosed |
| WO-2002100814-A1 | METHOD FOR PRODUCING (METH)ACRYLIC ACID ESTERS | BASF AKTIENGESELLSCHAFT (DE) | 2002-12-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040171868-A1 | Method for producing (meth) acrylic acid esters | ADH1A, ADH5, ADH1C | MAOB 1889/4885DAO 38/4885HRH3 673/4885 |
| US-20060211880-A1 | Method for the continuous production of alkyl(meth)acrylates with multiple catalyst recycling | ADH5, ADH1A, ADH1C | MAOB 1151/4885DAO 465/4885HRH3 3216/4885 |
| US-20040158096-A1 | Method for producing (meth)acrylic acid esters | ADH1A, ADH5, ADH1C | MAOB 1307/4885DAO 97/4885HRH3 1079/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.